-
Signature
-
/s/ Christopher Krueger, as Attorney-in-Fact
-
Stock symbol
-
VTYX
-
Transactions as of
-
Jul 31, 2023
-
Transactions value $
-
-$265,546
-
Form type
-
4
-
Date filed
-
8/1/2023, 04:21 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
VTYX |
Common Stock |
Options Exercise |
$177K |
+11.9K |
+24.59% |
$14.85 |
60.3K |
Jul 31, 2023 |
Direct |
|
transaction |
VTYX |
Common Stock |
Sale |
-$442K |
-11.9K |
-19.74% |
$37.16 |
48.4K |
Jul 31, 2023 |
Direct |
F1, F2 |
holding |
VTYX |
Common Stock |
|
|
|
|
|
27.7K |
Jul 31, 2023 |
By Spouse |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
VTYX |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-11.9K |
-1.73% |
$0.00 |
676K |
Jul 31, 2023 |
Common Stock |
11.9K |
$14.85 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
President and Chief Medical Officer